Bridges Investment Management Inc Amgen Inc Transaction History

Bridges Investment Management Inc

$6.51 Billion
Q2 2024

A detailed history of Bridges Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Bridges Investment Management Inc holds 94,503 shares of AMGN stock, worth $31.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

94,503

Previous 30,699 207.84%

Holding current value

$31.4 Million

Previous $8.73 Million 238.3%

% of portfolio

0.45%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $16.8 Million - $20.4 Million	63,804 Added 207.84%	94,503 $29.5 Million
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $665,722 - $803,610	2,476 Added 8.77%	30,699 $8.73 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $536,970 - $605,766	-2,100 Reduced 6.93%	28,223 $8.13 Million
Q3 2023 Oct 24, 2023	SELL	$218.65 - $271.46 $209,685 - $260,330	-959 Reduced 3.07%	30,323 $8.15 Million
Q2 2023 Jul 07, 2023	SELL	$214.27 - $253.37 $312,834 - $369,920	-1,460 Reduced 4.46%	31,282 $6.95 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $46,964 - $57,241	-208 Reduced 0.63%	32,742 $7.92 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $506,385 - $643,423	2,211 Added 7.19%	32,950 $8.65 Million
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $192,811 - $217,455	-859 Reduced 2.72%	30,739 $6.93 Million
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $21,686 - $24,133	-94 Reduced 0.3%	31,598 $7.69 Million
Q1 2022 Apr 08, 2022	SELL	$219.27 - $242.57 $31,794 - $35,172	-145 Reduced 0.46%	31,692 $7.66 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $829,329 - $949,092	4,170 Added 15.07%	31,837 $7.16 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $24,411 - $28,600	115 Added 0.42%	27,667 $5.88 Million
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $678,549 - $752,801	-2,905 Reduced 9.54%	27,552 $6.72 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $2.58 Million - $3 Million	-11,610 Reduced 27.6%	30,457 $7.58 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $929,135 - $1.11 Million	-4,294 Reduced 9.26%	42,067 $9.67 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $202,033 - $224,677	861 Added 1.89%	46,361 $11.8 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $408,082 - $500,772	-2,063 Reduced 4.34%	45,500 $10.7 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $769,781 - $1.02 Million	-4,224 Reduced 8.16%	47,563 $9.64 Million
Q4 2019 Feb 18, 2020	SELL	$189.21 - $243.2 $453,536 - $582,950	-2,397 Reduced 4.42%	51,787 $12.5 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $205,623 - $246,380	1,181 Added 2.23%	54,184 $10.5 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $77,515 - $90,865	-465 Reduced 0.87%	53,003 $9.77 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $53,899 - $60,756	298 Added 0.56%	53,468 $10.2 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $758,556 - $885,479	4,252 Added 8.69%	53,170 $10.4 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $75,042 - $84,600	405 Added 0.83%	48,918 $10.1 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $26,900 - $30,214	-162 Reduced 0.33%	48,513 $8.96 Million
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $277,865 - $324,720	1,640 Added 3.49%	48,675 $8.3 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.46 Million - $1.63 Million	-8,653 Reduced 15.54%	47,035 $8.18 Million
Q3 2017 Oct 05, 2017	BUY	$167.29 - $191.0 $2.76 Million - $3.15 Million	16,477 Added 42.02%	55,688 $10.4 Million
Q3 2017 Oct 02, 2017	BUY	$167.29 - $191.0 $6.56 Million - $7.49 Million	39,211	39,211 $7.31 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.

Account

Bridges Investment Management Inc Amgen Inc Transaction History